Systems and methods for detecting leakage currents in high-frequency ablation systems

Patent metadata

Field	Value
Publication number	US-12256986-B2
Application number	US-202117378597-A
Country	US
Kind code	B2
Filing date	Jul 16, 2021
Priority date	Dec 16, 2020
Publication date	Mar 25, 2025
Grant date	Mar 25, 2025

Abstract

The present disclosure provides systems and methods for detecting leakage currents in radio-frequency (RF) ablation systems. An RF generator may be configured to disable an electrical return path from a patient to a ground terminal. The RF generator may also be configured to apply an electrical signal to an electrode that is positioned to be in proximity to target tissue of the patient. The RF generator may be further configured to measure a leakage impedance while the electrical return path is disabled and the electrical signal is applied to the electrode. The RF generator may also be configured to control RF ablation therapy based, at least in part, on the measured leakage impedance. Other features are also claimed and described.

First claim

What is claimed is:

1. A method for controlling a radio-frequency (RF) ablation system, comprising:
disabling an electrical return path from a patient to a ground terminal;
applying an electrical signal to an electrode that is positioned to be in proximity to target tissue of the patient;
measuring a leakage impedance while the electrical return path is disabled and the electrical signal is applied to the electrode; and
controlling RF ablation therapy based, at least in part, on the measured leakage impedance.

2. The method of claim 1 , wherein the controlling of the RF ablation therapy based, at least in part, on the measured leakage impedance includes disabling RF ablation therapy when the leakage impedance is less than a first threshold impedance.

3. The method of claim 1 , wherein the controlling of the RF ablation therapy based, at least in part, on the measured leakage impedance includes disabling RF ablation therapy when a difference between the leakage impedance and a reference impedance is greater than a second threshold impedance.

4. The method of claim 1 , wherein the controlling of the RF ablation therapy based, at least in part, on the measured leakage impedance includes disabling RF ablation therapy, and wherein disabling RF ablation therapy includes preventing a start of RF ablation therapy.

5. The method of claim 1 , wherein the controlling of the RF ablation therapy based, at least in part, on the measured leakage impedance includes disabling RF ablation therapy, and wherein disabling RF ablation therapy includes preventing additional RF ablation therapy after RF ablation therapy has started.

6. The method of claim 1 , wherein the leakage impedance includes impedance observed by an electrical source of the RF ablation system when the electrical return path is disabled.

7. The method of claim 1 , wherein the leakage impedance is measured at least one of:
before a start of RF ablation therapy; or
after RF ablation therapy has started.

8. The method of claim 1 , wherein the leakage impedance is measured periodically after RF ablation therapy has started.

Assignees

• Advanced Neuromodulation Systems Inc

Inventors

• Oh Seil
• Balasingh Binesh
• Winstrom William
• Singh Simran

Classifications

• A61B18/1206 Primary

  Generators therefor · CPC title

• A61B2018/00577

  Ablation · CPC title

• A61B2018/1253

  monopolar · CPC title

• A61B2018/00678

  upper · CPC title

• A61B2018/00666

  using a threshold value · CPC title